Detalhe da pesquisa
1.
Long-term experience with tepotinib in Japanese patients with MET exon 14 skipping NSCLC from the Phase II VISION study.
Cancer Sci
; 115(4): 1296-1305, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38402853
2.
Neoadjuvant nivolumab plus chemotherapy in resectable non-small-cell lung cancer in Japanese patients from CheckMate 816.
Cancer Sci
; 115(2): 540-554, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38098261
3.
A multicenter, open-label, single-arm study of anamorelin (ONO-7643) in patients with cancer cachexia and low body mass index.
Cancer
; 128(10): 2025-2035, 2022 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35195274
4.
Nintedanib plus chemotherapy for nonsmall cell lung cancer with idiopathic pulmonary fibrosis: a randomised phase 3 trial.
Eur Respir J
; 60(6)2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35361630
5.
Uncommon EGFR mutations conducted with osimertinib in patients with NSCLC: a study protocol of phase 2 study (UNICORN/TCOG1901).
Future Oncol
; 18(5): 523-531, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35034503
6.
A quantitative evaluation of the histological type dependence of the programmed death-ligand 1 expression in non-small cell lung cancer including various adenocarcinoma subtypes: a cross-sectional study.
Jpn J Clin Oncol
; 52(3): 281-285, 2022 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34969085
7.
First-line pembrolizumab vs chemotherapy in metastatic non-small-cell lung cancer: KEYNOTE-024 Japan subset.
Cancer Sci
; 112(12): 5000-5010, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34543477
8.
Phase 1b study of ramucirumab in combination with erlotinib or osimertinib for untreated EGFR-mutated non-small cell lung cancer patients with asymptomatic brain metastases.
Invest New Drugs
; 39(6): 1598-1603, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34215931
9.
Phase 2 study of bevacizumab plus carboplatin/nab-paclitaxel followed by bevacizumab plus nab-paclitaxel for non-squamous non-small cell lung cancer with malignant pleural effusion.
Invest New Drugs
; 39(4): 1106-1112, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33544282
10.
Tepotinib in patients with NSCLC harbouring MET exon 14 skipping: Japanese subset analysis from the Phase II VISION study.
Jpn J Clin Oncol
; 51(8): 1261-1268, 2021 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34037224
11.
Five-year follow-up results from phase II studies of nivolumab in Japanese patients with previously treated advanced non-small cell lung cancer: pooled analysis of the ONO-4538-05 and ONO-4538-06 studies.
Jpn J Clin Oncol
; 51(1): 106-113, 2021 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33020837
12.
First-line pembrolizumab vs chemotherapy in metastatic non-small-cell lung cancer: KEYNOTE-024 Japan subset.
Cancer Sci
; 111(12): 4480-4489, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32926507
13.
Phase1 study of cisplatin plus pemetrexed with erlotinib and bevacizumab for chemotherapy-naïve advanced non-squamous non-small cell lung cancer with EGFR mutations.
Invest New Drugs
; 36(4): 608-614, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29101518
14.
A phase I/II trial of pemetrexed plus radiotherapy in elderly patients with locally advanced non-small cell lung cancer.
Invest New Drugs
; 36(4): 667-673, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29572782
15.
Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non-small cell lung cancer.
Cancer Sci
; 108(5): 1000-1006, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28266091
16.
Phase I/II study of docetaxel combined with resminostat, an oral hydroxamic acid HDAC inhibitor, for advanced non-small cell lung cancer in patients previously treated with platinum-based chemotherapy.
Invest New Drugs
; 35(2): 217-226, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28138828
17.
Severe acute interstitial lung disease after nivolumab in three non-small cell lung cancer patients with imaging findings of airway obstruction adjacent to lung tumors.
J Infect Chemother
; 23(12): 826-829, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28818548
18.
Erlotinib for Japanese patients with activating EGFR mutation-positive non-small-cell lung cancer: combined analyses from two Phase II studies.
Future Oncol
; 12(18): 2117-26, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-27267081
19.
Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial.
Support Care Cancer
; 24(8): 3495-505, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27005463
20.
Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients-Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study.
Support Care Cancer
; 24(8): 3473-80, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27003901